The Case Against Antipsychotics

130
This review of the scientific literature, stretching across six decades, makes the case that antipsychotics, over the long-term, do more harm than good. The drugs lower recovery rates and worsen functional outcomes over longer periods of time.

New Rating Tool for Tapering Antidepressants and Antipsychotics

1
Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.

2nd-Generation Antipsychotics Cause Extrapyramidal Side Effects as Much as 1st-Generation

7
According to researchers from Yale and the U.K., the improvements in extrapyramidal side effects expected from 2nd-generation antipsychotics has not been realized, while the...

How Do We Test the Effects of Long-Term Exposure to Antipsychotics?

39
A new attempt to study the neurological effects of long-term exposure to antipsychotics uses healthy volunteers on minimal doses for 15 days.

Review Explores First-Person Experiences of People Taking Antipsychotics

56
A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.

Antipsychotics During Pregnancy Raise Diabetes Risk

0
Swedish researchers find, in a study of all women giving birth in Sweden from July 1, 2005 through December 31, 2009 that those taking...

Researchers Call for Reappraisal of Adverse Mental Effects of Antipsychotics, NIDS

9
In a study published yesterday, researchers from the Nippon Medical School in Tokyo bring attention to a condition known as neuroleptic-induced deficit syndrome (NIDS)...

PTSD and Psychiatric Medication Linked to Dementia in Older Veterans

1
Veterans diagnosed with PTSD and taking SSRIs, novel antidepressants, or atypical antipsychotics are more likely to develop dementia.

In Chronic Patients, Antipsychotics Have Limited Efficacy in Reducing Symptoms

6
A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.

20-Year Data Show Antipsychotics Do Not Reduce Psychosis

13
Martin Harrow's study tracing the effects of antipsychotics on 139 schizophrenia (SZ) and mood-disordered patients over 20 years, just published in Psychological Medicine, finds...

Neuroleptic Malignant Syndrome Linked to Polypharmacy, Benzos, and Race

0
Research from London and Taipei finds that neuroleptic malignant syndrome (NMS) is associated with the number of different antipsychotics used (polypharmacy), rather than the overall...

Anticholinergic Drugs Increase Risk of Cognitive Decline

10
A new study finds that anticholinergic drugs, like antidepressants and antipsychotics, are associated with mild cognitive decline.

Long-term Outcomes Better for Those Who Stop Taking Antipsychotics

11
Research undermines the prolonged use of antipsychotics in schizophrenia treatment, suggesting improved social functioning and quality of life with discontinuation.

Discontinuing Psychotropics Reduces Falls in Elderly

0
Australian researchers look at the literature on the effect of psychotropics on falls in the elderly; largest effect of any randomized trial was achieved...
Young man refusing to take prescribed pills in clinic

Antipsychotics Lead to Worse Outcomes in First-Episode Psychosis

23
Those who did not get antipsychotics in the first month were almost twice as likely to be in recovery after five years.

Assessing Increased Mortality Risks of Antipsychotics and Mood Stabilizers in Dementia

0
An article in January's American Journal of Psychiatry weighs the relative risk of mortality associated with various antipsychotics and mood stabilizers used in the treatment of...

Antipsychotics Increase Risk of Heart Attack in the Elderly

0
In a study of 10,969 older patients treated with antipsychotics in Quebec, Canada, researchers found a 2.19 times greater risk of heart attack in...

A History of Rapid Tranquilization

0
A paper by Joanna Moncrieff and Laura Allison in the journal History of Psychiatry reviews "the theory and practice of emergency sedation for behavioural...

New Review of Antipsychotics for Schizophrenia Questions Evidence for Long Term Use

11
A systematic review of the limited research available on the long-term effects of antipsychotics finds fewer symptoms in those off of the drugs.

Antipsychotics Rise in Youth, But Hospitalization Rates Stay the Same

2
Researchers from Tufts and Harvard find in a review of 233 medical charts of psychiatrically hospitalized youth at three points in time (1991, 1998...

Review Finds FDA Approval of Digital Antipsychotic Misguided

8
The approval of the digital antipsychotic may open the door for more pharmaceutical company profits without evidence of benefits to patients.

Increased Risk of Movement Disorders From Antipsychotics in Persons with Intellectual Disabilities

4
Large cohort study demonstrates that those with an intellectual disability are at an increased risk for movement disorder side effects of antipsychotics.

Children Diagnosed with ADHD Younger are More Likely to get Multiple Medications

4
New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.

Antipsychotics Associated with Severe COVID-19 and Fatal Outcomes

4
A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.

Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain

90
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.